BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07382739-completion@plaintrial.com
DTSTAMP:20260926T051257Z
DTSTART;VALUE=DATE:20301231
SUMMARY:A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance E
 lranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extr
 amedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD" 
 — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07382739
URL:https://plaintrial.com/trial/NCT07382739
END:VEVENT
END:VCALENDAR